To siRNA with Love

Just as the use of RNA interference has mushroomed throughout the world over the last six years, the number of bioinformatics tools to screen for siRNA has blossomed, too. More than a half-dozen proprietary and open-source programs are available, many sponsored by siRNA and reagent vendors.So Jonathan Rux, a bioinformatician at the Wistar Institute at the University of Pennsylvania, was surprised to find that all these resources lacked a critical tool: They didn't account for gene specificity. S

Written bySam Jaffe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Just as the use of RNA interference has mushroomed throughout the world over the last six years, the number of bioinformatics tools to screen for siRNA has blossomed, too. More than a half-dozen proprietary and open-source programs are available, many sponsored by siRNA and reagent vendors.

So Jonathan Rux, a bioinformatician at the Wistar Institute at the University of Pennsylvania, was surprised to find that all these resources lacked a critical tool: They didn't account for gene specificity. Selecting siRNA is more complicated than choosing a code complementary to the sequence of the RNA to be silenced, because siRNA can sometimes silence multiple genes and its effects can often be unpredictable, Rux says.

That's why Rux and his colleague, Natasha Levenkova, designed the siRNA Selector. "It allows you to select an siRNA that not only silences your gene, but ensures that you're not setting off some incidental chain reaction that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies